Health care executive coaches explain why leaders aren't feeling holly-jolly this year. Plus, Shiv Rao on Abridge's next moves.

A major review in Frontiers in Science highlights how tackling unsustainable food systems—reflected by our changing food ...

This research delves into the association between anti-diabetic medications and cancer, exploring mechanisms beyond just ...

Afon Technology, aims to transform diabetes management with its non-invasive glucose monitoring device, GlucowearTM ...

"Holiday heart syndrome" is an umbrella term for several cardiac complications that occur during the winter holiday season.

A new study led by Queen’s University Belfast researchers has explored the potential of the drug 2-HDP for protecting vision in diabetes patients ...

Environmental exposures are emerging as major contributors to autoimmune risk: Studies link air pollution, PFAS, and ...

At present, around 59 million adults worldwide have diabetes, about 64 million are diagnosed with heart failure, and ...

The discovery could lead to the development of personalised risk prediction tools and help doctors identify people who may ...

Features of urban areas, such as street connectivity or access to green spaces, can impact cardiometabolic health. However, ...

People who brought their blood glucose down to a normal level had a lower risk of death from heart disease or hospitalization ...

Groundbreaking discovery finds genetic links to pancreatic cancer - Discovery could revolutionise early identification and ...